Global Lab Automation in Genomics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

Lab Automation in Genomics Market Analysis

The Global Lab Automation in the Genomics market is expected to grow by registering a CAGR of 7.5% during the forecast period. There has been a significant improvement in understanding of genome sequencing in terms of data analytics advances that reveal unknown correlations, hidden patterns, and other insights, especially when testing data sets on a large scale. This is due to technological advancements and increasing computational capacities driving the market.

• The development of genomics, which uses the availability of whole DNA sequences for entire organisms, is due to the innovative work of a few genomics giants and the more recent next-generation sequencing technology.
• The speed, volume, and price of genome sequencing have all dramatically increased because of the development of next-generation sequence technologies. Additionally, hundreds of life-science databases and programs that promote scientific study have been made possible because of advancements in bioinformatics. These databases make it simple to search, contrast and analyze the information that is organized and kept there.
• Furthermore, significant medical advancements are occurring quickly, mostly due to recent improvements in genomic analysis. DNA sequence analysis clarifies how genetic diversity causes disease and ultimately results in novel treatments. Additionally, laboratory automation has opened space for innovative flexibility, increased throughput, and cost-effective solutions. It allows for quick handling and enables the process to be sped up without worrying about accuracy and dependability. Due to the low cost of genotyping and DNA sequencing, the expansion rate is strong.
• Genetic testing start-ups have been springing up like daisies due to improvements in DNA sequencing technology that have made it more affordable and widely available. However, the knowledge of whole genomes has made functional genomics viable, particularly interested in gene expression patterns under various situations, making it possible for genome sequencing programs to increase rapidly in breadth and speed. The most important tools, in this case, are microarrays and bioinformatics.
• Nucleic acid isolation, RNAi screening, CRISPR analysis, PCR, and gene expression analysis are just a few of the genomics applications that use automation. Laboratory automation players/vendors are developing tools to meet these application requirements. For example, Tecan Group introduced its new "Fluent Automation Workstation" platform in July 2021, which incorporates a variety of capabilities to simplify day-to-day laboratory automation and increase workflow productivity. During a run, the system reacts dynamically, adjusting based on actual times to maintain continuous optimal throughput, all of which are visible in real-time via an easy-to-understand Gantt chart.
• The companies are developing new products or incorporating new features in the existing products to meet the needs of the customer. For instance, in March 2022, Firefly, a revolutionary liquid handling platform for next-generation sequencing (NGS) library preparation, has been launched by SPT Labtech, a pioneer in designing and developing automated apparatus and consumables for life science applications. Firefly changes NGS liquid handling operations by combining pipetting and dispensing inside a small all-in-one design, paving the path for a new age of genomics laboratory automation. With numerous user levels, clever programming, and a fully visible audit trail, the platform establishes a new standard in sophisticated, intuitive liquid handling software and hardware capabilities.
• The COVID-19 pandemic has highlighted the difficulties of high-throughput molecular testing, necessitating a more integrated method to satisfy workload demands without sacrificing results quality and various partnerships are witnessed in the market focusing on molecular testing. For instance, in February 2021, Tecan, a products, services, and solutions provider for lab processes and medical procedures, and UgenTec, a laboratory software company, announced a partnership to produce fully integrated sample-to-result PCR workflow solutions. Tecan's liquid handling and automation capabilities will be combined with UgenTec's FastFindersoftware, combining end-to-end automation with extensive data analysis and workflow tools to provide high throughput molecular testing solutions.

Lab Automation in Genomics Industry Segmentation

The use of instrumentation to perform laboratory activities with minimum human involvement is known as lab automation. Automation can be used for any part of an experimental process, from a single step to the full workflow. Lab automation is divided into three stages: pre-analytical, analytical, and post-analytical. Automated processes can be applied to all aspects of the experimental process. The scope of the study focuses on the market analysis of lab automation in genomics across the world, and market sizing encompasses the revenue generated by these products sold by various market players.

The Global Lab Automation in Genomics Market is Segmented by Equipment (Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage and Retrieval Systems, and Vision Systems) and Geography.

Report scope can be customized per your requirements. Click here.

Lab Automation in Genomics Market Trends

This section covers the major market trends shaping the Lab Automation in Genomics Market according to our research experts:

Automated Liquid Handlers to Witness High Growth

To understand key trends, Download Sample Report